JAKARTA - PT Bank Rakyat Indonesia (Persero) Tbk or BRI is collaborating with PT Bio Farma (Persero) as the holding of Pharmaceutical State-Owned Enterprises (BUMN) to build a healthcare ecosystem.
These two companies are building an ecosystem by developing the Medbiz platform, namely the end-to-end marketplace for the distribution of medicines and medical devices aimed at retailers to connect with multi distributors or sellers in the pharmaceutical sector.
BRI's Director of Small and Medium Business Amam Sukriyanto said that this collaboration is expected to make it easier for the public to access various needs in the health sector.
"With the convenience of transactions, everything can be done completely non-cash, so it is more effective and efficient. In addition, the facilities that can be utilized for retailers also boost business actors or MSMEs," Amam said, quoted from Antara, Friday, February 3.
Through the Medbiz Card provided by BRI, customers can make transactions with a limit of up to IDR 200 million. That way, it is hoped that BRI banking services can be an option for Medbiz partners who want to purchase health products through MedBiz, in line with the various promotions offered.
In this case, BRI acts as a payment system provider bank on the Medbiz platform, such as Medbizcard, BRIVA payment features, payments using acaly paylater, and financing through financial distributors.
Celebrating is a digital loan service that provides convenience for transaction financing through e-Commerce with a limit of up to IDR 20 million and a process in less than 10 minutes.
"BRI and Bio Farma are also focused on fostering MSMEs through providing financing to business actors in the pharmaceutical and health sectors," said Amam.
All of this cooperation, he said, is integrated in a system so that it provides accessibility and convenience for the community to take advantage of financial services from BRI and ease of accessing health services.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
